Researchers finds Irish Lupus patients likely to benefit from new treatment
Researchers from the Royal College of Surgeons in Ireland (RCSI) have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus (SLE) could potentially benefit Irish patients who suffer from ...
Arthritis & Rheumatism
May 07, 2013 |
not rated yet |
0
Possible treatment for serious blood cancer
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
Cancer
May 06, 2013 |
5 / 5 (1) |
0
'Oil for the joints' offers hope for osteoarthritis sufferers
A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers. The new synthetic polymer supplements ...
Arthritis & Rheumatism
May 02, 2013 |
4 / 5 (1) |
0
Scientists weaken HIV infection in immune cells using synthetic agents
HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy. But researchers at Temple ...
HIV & AIDS
May 01, 2013 |
5 / 5 (2) |
0
|
Pfizer Q1 profit up, but drugmaker cuts outlook
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's ...
Other
Apr 30, 2013 |
not rated yet |
0
Foul-smelling gas shows health benefits in reducing joint swelling
A gas associated with the smell of rotten eggs has proven to effectively reduce joint swelling, in research which could lead to advances in the treatment of arthritis.
Arthritis & Rheumatism
Apr 29, 2013 |
not rated yet |
0
Development of novel therapies for endothelial damage may heal atherosclerotic plaques
Heart disease and approximately half of all strokes are the results of advanced atherosclerosis with damaged endothelium, the inner lining of blood vessels. In 2009, the direct and indirect annual cost of heart disease and ...
Cardiology
Apr 21, 2013 |
not rated yet |
0
Use of biologic therapies for inflammatory diseases does not appear to increase risk of shingles
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic ...
Inflammatory disorders
Apr 19, 2013 |
not rated yet |
0
Cell-destroyer that fights and promotes TB reveals what's behind its split identity
Tumor necrosis factor—normally an infection-fighting substance produced by the body—can actually heighten susceptibility to tuberculosis if its levels are too high. University of Washington TB researchers ...
Diseases, Conditions, Syndromes
Apr 11, 2013 |
5 / 5 (1) |
0
|
Key pathway to stop dangerous, out-of-control inflammation discovered
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.
Inflammatory disorders
Apr 09, 2013 |
5 / 5 (4) |
0
|
Will cell therapy become a 'third pillar' of medicine?
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers. They outlined ...
Medical research
Apr 03, 2013 |
5 / 5 (8) |
0
|
Study reveals how diabetes drug delays ageing in worms
A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.
Medical research
Mar 28, 2013 |
4.5 / 5 (2) |
0
|
Team discovers how drug prevents aging and cancer progression
University of Montreal researchers have discovered a novel molecular mechanism that can potentially slows the aging process and may prevent the progression of some cancers. In the March 23 online edition of the prestigious ...
Medical research
Mar 27, 2013 |
5 / 5 (2) |
0
|
'Clinical trials in a dish' may be more reliable than standard way of measuring drug effects on heart, researchers say
(Medical Xpress)—Last week, the common antibiotic Zithromax received a new warning label from the U.S. Food and Drug Administration indicating it could cause dangerous arrhythmias in people with pre-existing heart conditions. ...
Medical research
Mar 22, 2013 |
5 / 5 (1) |
0
|
Pain reliever naproxen shows anti-viral activity against flu
The over-the-counter anti-inflammatory drug naproxen may also exhibit antiviral activity against influenza A virus, according to a team of French scientists. The finding, the result of a structure-based investigation, is ...
Medications
Mar 21, 2013 |
5 / 5 (1) |
0
|
